Symposium Preceding the 59th American Society of Hematology Annual Meeting
Evidence- and Value-Based Approaches to Pathology and Laboratory Diagnosis and Prognosis of Common Hematologic Neoplasms: A Case-Based Illustration
Atlanta Marriott Marquis Symposium Room: Atrium A Atlanta, Georgia December 8, 2017
DescriptionThis program’s overall objective is to update the practicing hematologists/oncologists and hematopathologists about the evolving repertoire of test options and appropriate testing strategies. We aim to inform participants on the most cost-effective, diagnostically efficient testing strategies in the evaluation of hematologic malignancies. Using data-driven testing algorithms derived from the Mayo Clinic Hematopathology/Hematology practice and available literature, we will illustrate how unnecessary, redundant, and costly laboratory tests can be eliminated from the participants’ practices while maintaining the highest quality medical care.
Intended AudienceHematologists/Oncologists, hematopathologists, pathologists, physician assistants, and nurse practitioners who provide care for patients with hematological neoplasms.
ObjectivesUpon completion of the conference, participants should be able to:
- Describe the algorithmic strategy for the diagnostic workup of diffuse large B-cell lymphoma and high-grade B-cell lymphoma.
- Discuss the utility of next-generation sequencing in myeloid malignancies.
- Discuss an evidence-based, algorithmic approach to the bone marrow workup of eosinophilia.
- Use algorithm-based stratification of patients for optimal treatment choice.